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Background: When hospitals suffer financial losses when postoperative complications occur, they may have a
direct financial incentive to initiate quality improvement programs. The purpose of this research was to determine
the relationship between complications following open colectomy and hospital finances.
Methods: After obtaining Institutional Review Board approval, we conducted a retrospective chart review of 276
open colectomies performed at the Hospital of the University of Pennsylvania. The medical records were manually
reviewed for complications that occurred within 30 days after surgery. Financial information, including total, fixed
and variable costs, was obtained from the hospital’s cost accounting database. Reimbursement assuming payment
by Medicare was calculated. Differences in costs, reimbursements and total margins were analyzed.
Results: Of 276 patient records reviewed, 61 (22%) of the patients experienced postoperative complications. When
complications occurred, mean total costs increased from $23,101 to $48,180, fixed costs increased from $14,516 to
$30,339 and variable costs increased from $8,535 to $17,848 (P < 0.001 for each comparison); the mean
reimbursement increased from $23,231 to $35,651 (P < 0.001); and the total margin decreased from $131
to − $12,528 (P < 0.001). Complications were associated with a more than twofold increase in length of stay in the
hospital. Multiple regression modeling indicated similar increases in each of the financial variables and length of
stay as a result of postoperative complications. The impact of these complications on each outcome measure was
similar in effect for patients in the matched subset of 100 patients.
Conclusion: Our results demonstrate a financial incentive for hospitals to investigate quality improvement
measures to prevent postoperative complications and avoid the associated financial losses.
Keywords: Cost, Complications, ColectomyBackground
Value is the new focus of the American health-care system
[1], with payers, providers and policy makers searching for
ways to improve outcomes and contain costs [2]. Complica-
tions following surgery are value-destroying events because
they contribute to poor outcomes while increasing the costs
borne by hospitals and health-care payers [3]. As a result,* Correspondence: lee.fleisher@uphs.upenn.edu
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unless otherwise stated.initiatives designed to prevent surgical complications, such
as the National Surgical Quality Improvement Program
(NSQIP), have gained increasing importance at both the in-
dividual hospital and nationwide levels [4].
The impact of improved health-care quality on hospital
finances is of great importance to hospital financial man-
agers and administrators. Launching an initiative to reduce
surgical complications requires allocation of scarce hospital
resources, potentially at the expense of alternative quality
improvement programs [5,6]. Quantifying the impact of
postoperative complications on hospital resources is there-
fore a useful exercise that can help financial managers opti-
mally allocate these resources to benefit both patients and
hospitals.td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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initiatives because of the large number of these opera-
tions performed each year and the high incidence of as-
sociated complications. The procedure, performed on
nearly 275,000 patients annually [7], has been shown in
several studies to have 30-day complication rates exceed-
ing 25% [8-10]. A 2008 study of 36 general surgical pro-
cedures involving more than 129,000 patients found that
colectomy, though it represented less than 10% of all
cases, was responsible for 24.3% of all adverse events
and the greatest share of morbidity, mortality and in-
creased length of stay (LOS) of the procedures studied
[9]. Furthermore, a majority of adverse events involving
colon resection are considered preventable [11], suggest-
ing that quality improvement applied to colon surgery
could be a particularly fruitful undertaking.
Although numerous studies have demonstrated that
surgical complications significantly increase hospital
costs, data regarding the overall financial impact of post-
operative complications on hospitals are scarce. Al-
though some of these additional costs may be offset by
higher reimbursement from payers [3,12], little is known
about the sources of increased hospital costs or the ex-
tent to which payers compensate hospitals for increased
expenses for postoperative complications.
We hypothesized that surgical complications would be fi-
nancially detrimental to hospitals, resulting in increased
costs and decreased profit margins. In this study, we exam-
ined the increment in hospital costs and reimbursements
associated with complications following open colectomies
at a large academic medical center. We modeled reim-
bursement under the simplifying assumption that all
patients were insured by Medicare. Using cost and reim-
bursement data, we calculated total margins (that is, profit-
ability) and compared the results between patients who
experienced complications and patients who did not. Fi-
nally, we discussed the implications of our results on the
financial case for complication prevention from the per-
spective of hospital financial managers and administrators.
Methods
Study design and setting
We conducted a retrospective review of all medical records
of patients who underwent open partial colectomy with
anastomosis during a 4-year period (2007 through 2010) at
the Hospital of the University of Pennsylvania, a large,
urban academic medical center. This study was conducted
after we received approval from the Institutional Review
Board of the University of Pennsylvania. Approval included
a waiver of documentation of informed consent, given the
retrospective, minimal risk nature of the research. The
study was conducted and reported in accordance with the
Strengthening the Reporting of Observational Studies in
Epidemiology statement for observational studies [13].Data sources
Patient data and dates of admissions were obtained from
the hospital’s administrative database. Complications
were identified by manual review of the hospital’s elec-
tronic medical records. Financial data were obtained
from the hospital’s internal cost accounting database
(Horizon Performance Manager Cost Accounting Sys-
tem; McKesson, San Francisco, CA, USA). The account-
ing system assigns a unit cost to each charge item or
service provided (excluding physicians’ professional fees)
using either the relative value unit (RVU) or ratio of cost
to charge (RCC) cost accounting methods. The RCC
method is used to determine the costs of medications
and supplies, and the RVU method is used to assign
costs to particular services, from both service centers
(for example, nursing or radiology) and support centers
(for example, information technology or housekeeping)
[7]. The costs for each item or service provided during
an encounter are then mapped to charge categories
(fixed costs, variable labor costs and variable supply
costs), which are then added to determine the total cost
of resources consumed during each encounter.
Participants
Study patients were located by searching the hospital’s ad-
ministrative database for Current Procedural Terminology
(CPT) code 41440 (open partial colectomy with anasto-
mosis). Study exclusion criteria included (1) age younger
than 18 years, (2) concomitant surgery involving an organ
outside the lower gastrointestinal (GI) tract, (3) failure to
perform surgery within 48 hours after hospital admission
and/or (4) incomplete medical or financial records. Demo-
graphic data collected for each patient included age, gender,
American Society of Anesthesiologists (ASA) physical sta-
tus score and body mass index (BMI).
Complications
Each patient’s electronic medical record was manually
reviewed for major complications occurring within 30 days
after surgery. Complications abstracted included deep
wound surgical site infection (SSI), organ/space infection
SSI, sepsis, Clostridium difficile colitis, pneumonia, myocar-
dial infarction, new-onset arrhythmia, cardiac arrest, pul-
monary embolism, acute renal failure and/or acute kidney
injury, cerebrovascular accident, hemorrhage requiring
transfusion of more than 4 U of packed red blood cells
(RBCs), bowel obstruction, reoperation, death and other
complications. Other complications included any condition
not present upon admission that could potentially be harm-
ful to the patient’s health that was documented in the med-
ical record by an attending physician. We used standard
American College of Surgeons NSQIP definitions when
available. C. difficile colitis and bowel obstruction were re-
corded on the basis of the attending physician’s diagnosis.
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Clinical data were merged with financial data to determine
the costs associated with each patient’s care. Costs exam-
ined included total costs, fixed costs and variable costs. For
patients who were readmitted to the hospital within 30 days
after the initial surgery, the cost of each inpatient encounter
was added to determine the total cost for all hospital ad-
missions. All costs were adjusted to 2010 US dollars (USD)
using the hospital inpatient services subcategory of the
Consumer Price Index (CPI) obtained from the US Bureau
of Labor Statistics [12].
The patients in this study were insured by various payers,
including Medicare, Medicaid and commercial insurers, so,
in addition to obtaining the actual payments, we calculated
expected reimbursements under the simplifying assump-
tion that all study patients were insured by Medicare only.
This step was included to eliminate the impact of payer
mix on financial outcomes, which may vary substantially
between hospitals and have a significant impact on reim-
bursement and overall profitability. We calculated the ex-
pected Medicare reimbursement for each patient using the
Medicare Severity Diagnosis-Related Group (MS-DRG)
payment rate at our hospital during each year of services.
(A brief overview of the Medicare system is provided in the
Appendix). A unique MS-DRG was assigned for each ad-
mission using an automated MS-DRG grouper based on
International Classification of Disease, Ninth Revision
(ICD-9) discharge and procedure codes (3M Co, St Paul,
MN, USA). Payment rates for 2007 were not available, so
the corresponding 2008 rates were used for patients treated
during 2007 and 2008. Payments were adjusted to 2010
USD using the general CPI. LOS was also calculated for
each patient. For patients who were readmitted within
30 days after surgery, LOS from the index visit and subse-
quent readmissions occurring within the study period were
added to determine the total LOS associated with the
procedure.
Statistical methods
Bivariate comparisons of continuous data were made
using Student’s t-test. The impact of complications on fi-
nancial variables was analyzed using multiple linear re-
gression analysis. Additional explanatory variables used
in the regression analysis included age, age-squared (to
allow for nonlinear effects of age on the rate of compli-
cations), gender, ASA classification and BMI.
To control for potential confounding effects resulting
from underlying differences between groups, we used
the Coarsened Exact Matching (CEM) algorithm [14] to
match patients who experienced complications on a
one-to-one basis to patients without complications. Pa-
tients were matched for age, gender, ASA classification
and BMI. CEM is relatively a new nonparametric match-
ing method developed to address limitations of morewidely used methods such as propensity score matching.
CEM has been described in detail elsewhere, so we will
discuss it here only briefly. When performing CEM, the
original values of the covariates are first coarsened, or
divided into two or more user-defined ranges or categor-
ies. The CEM algorithm is then used to create a set of
strata, each of which contains variables that share identi-
cal coarsened values for every covariate. Strata that con-
tain patients in both the treatment and control groups
are retained, and patients from the treatment group and
control group paired within each stratum. After match-
ing has been performed, the coarsened values are re-
placed by their original values, allowing subsequent
analysis of the uncoarsened values of each covariate to
proceed.
We used CEM because it offers several advantages
over existing methods, such as Propensity Score Match-
ing (PSM). First, CEM is a member of the Monotonic
Imbalance Bounding (MIB) class of matching methods,
which generalizes the Equal Percent Bias Reducing
(EPBR) class (comprising PSM and many other popular
matching methods, such as Mahalanobis matching, Gen-
etic Matching and others), eliminating key assumptions
required to generate unbiased estimates of treatment ef-
fects. Second, with CEM, the process used to create
matches is reversed. With CEM (and MIB methods in
general), the user chooses the maximum level of imbal-
ance ex ante (determined by the level of coarsening),
with the number of matches produced as a result. With
EPBR methods, the number of matched observations is
chosen ex ante, with an unknown amount of imbalance
produced as a result. Thus, with CEM, the need for re-
peated postmatch balance-checking, model modification
and rematching required by other methods is eliminated,
although the level of coarsening may need to be altered
to produce a satisfactory sample size. Third, with CEM,
the imbalance on one covariate can be changed in isola-
tion without affecting the imbalance on any other covar-
iates. This contrasts with EPBR methods, in which
altering the imbalance on one covariate changes the im-
balance on all other covariates, sometimes in unpredict-
able ways. Fourth, CEM has been shown through
simulation on multiple data sets to be superior to alter-
native matching methods by producing matches with re-
duced imbalance, bias, variance, model dependence,
estimation error and mean square error [15,16].
All statistical analyses were conducted using Stata version
11.0 software (StataCorp, Austin, TX, USA). For all calcula-
tions, statistical significance was defined by P-values less
than 0.05.
Results
A total of 380 patients were identified, 276 of whom met
our inclusion criteria. Reasons for exclusion included
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patients), surgery more than 48 hours after admission (48
patients) and incomplete medical or financial records (3 pa-
tients). An additional six patients met two exclusion criteria
because they had concomitant surgery outside the GI tract
more than 48 hours after admission.
Among the 276 included patients, 61 patients (22% of the
total) experienced one or more major complications
(Table 1). The most common complication was organ/
space SSI (5.1% of patients), followed by new-onset
arrhythmia (4.7%), reoperation (4.7%) and bowel obstruc-
tion (4.0%). All other complications were relatively uncom-
mon, occurring in fewer than 3.0% of patients. Only one
patient death occurred, which followed the only recorded
cardiac arrest (believed to be precipitated by a massive pul-
monary embolism). Postoperative complications were often
related. For example, 9 of the 13 reoperations were per-
formed as a result of either deep SSI or organ and/or surgi-
cal space infections.
Unmatched sample
There were no statistically significant differences between
patient groups with respect to age, gender, BMI or ASA
classification in the unmatched samples (Table 2). However,
patients in the complications group tended to be older,
more often male and had higher ASA scores than those inTable 1 Number and incidence of complicationsa
Complications Number of patients %
Deep SSI 5 1.8%
Organ/space SSI 14 5.1%
Sepsis 5 1.8%
Clostridium difficile colitis 4 1.4%
Pneumonia 8 2.9%
Bowel obstruction 11 4.0%
Acute kidney injury 6 2.2%
Cerebrovascular accident 2 0.7%
Pulmonary embolism 4 1.4%
New-onset arrhythmia 13 4.7%
Myocardial infarction 5 1.8%
Cardiac arrest 1 0.4%
Unplanned intubation 6 2.2%
Reoperation 13 4.7%
Death 1 0.4%
Other infections 7 2.5%
aSSI: Surgical site infection. The category “Other infections” included
readmission for unexplained severe gastritis, hypotension of unknown cause
prompting transfer to the surgical intensive care unit (SICU), upper-extremity
ischemia presumed to be caused by vasospasm, respiratory depression from
opiate overdose requiring SICU transfer, readmission for biliary colic requiring
surgical intervention, readmission for chylous ascites requiring paracentesis
and postdural puncture headache requiring epidural blood patch (n = 1 for
each complication).the uncomplicated group. Mean LOS was more than twice
as long for patients who experienced complications
(15.6 days) than for those who had no complications
(7.3 days).
Complications were associated with dramatic increases
in total, fixed and variable costs; increased reimburse-
ments; and decreased total margins (Table 2). The mean
total cost was $23,101 for patients in the uncomplicated
group compared to $48,180 for those in the complica-
tions group, a difference of $24,079. Fixed and variable
costs were more than doubled when complications oc-
curred. Mean reimbursement was $12,420 higher for pa-
tients in the complications group ($35,651) than for
patients in the uncomplicated group ($23,231). Patients
in the uncomplicated group generated a small but posi-
tive total margin (that is, gain) of $131 per patient,
whereas patients in the complications group generated a
large negative total margin (that is, loss) of $12,528 per
patient.
Table 3 displays the results of the multiple linear re-
gression analysis for each outcome variable, adjusted for
the effects of age, age-squared, gender, ASA classifica-
tion and BMI. The results of this analysis were similar to
the unadjusted differences between the two groups with
regard to the mean values (Table 2). Complications were
associated with an increase in total cost of $24,889, an
increase in reimbursement of $12,326 and a decrease in
total margin of $12,563.
Matched sample
The 50 patients in who experienced complications were
matched to 50 similar patients who without complica-
tions. Suitable matches were not found for the
remaining 11 patients who had complications. Differ-
ences in age, gender, BMI and ASA classification were
minimal between complication groups in the matched
sample (Table 2).
Complications were associated an increase in total
costs of $26,351, an increase in reimbursement of
$12,108 and a decrease in total margin of $14,244. Com-
plications were associated with an increase in LOS of
8.5 days.
The results of the multivariate regression analysis
(Table 3) were nearly identical to the unadjusted results.
After adjustment, complications were associated with an
increase in total cost of $26,269, an increase in reim-
bursement of $12,138 and a decrease in total margin of
$14,131.
Discussion
The purpose of this study was to evaluate the financial im-
pact of surgical complications following open colectomy
from the perspective of hospital financial managers and ad-
ministrators. To eliminate the impact of payer mix on our
Table 2 Patient demographic data, length of stay and financial data by complication group for matched and
unmatched samplesa
Entire cohort (N = 276) Matched sample (n = 100)
Variable Uncomplicated Complications P-value Difference Uncomplicated Complications P-value Difference
Patients, n (%) 215 (78%) 61 (22%) – – 50 50 – –
Mean age, years (SD) 60.2 (14.8) 62.9 (13.3) 0.20 2.7 63.6 (12.9) 63.7 (12.3) 0.97 0.1
Females, n (%) 113 (53%) 27 (44%) 0.25 – 24 (48%) 24 (48%) 1.0 –
ASA class, mean (SD) 2.5 (0.5) 2.6 (0.5) 0.21 0.1 2.6 (0.50) 2.6 (0.50) 1.0 0
BMI, mean (SD) 28.4 (7.3) 28.7 (6.3) 0.74 0.3 28.1 (6.4) 28.2 (5.7) 0.93 0.1
LOS (days), mean (SD) 7.3 (2.4) 15.6 (7.8) <0.001 8.3 7.4 (2.1) 15.9 (7.5) <0.001 8.5
Total cost, mean (SD) $23,101 (6,914) $48,180 (26,596) <0.001 $25,079 $23,381 (6,712) $49,733 (28,279) <0.001 $26,351
Fixed cost, mean (SD) $14,516 (4,252) $30,229 (16,340) <0.001 $15,713 $14,807 (4,509) $31,233 (17,333) <0.001 $16,426
Variable cost, mean (SD) $8,535 (2,904) $17,848 (10,356) <0.001 $9,313 $8,526 (2,656) $18,397 (11,066) <0.001 $9,871
Reimbursement, mean (SD) $23,231 (6,761) $35,651 (13,445) <0.001 $12,420 $23,632 (7,110) $35,739 (13,327) <0.001 $12,108
Total margin, mean (SD) $131 (8,309) −$12,528 (26,113) 0.001 −$12,659 $250 (7,781) −$13,993 (27,144) <0.001 −$14,244
aASA: American Society of Anesthesiology; BMI: Body mass index. Total margin = Reimbursement − Total cost. Financial data are US dollars.
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included in the study were insured by Medicare. We found
that major surgical complications were associated with
higher total hospital cost and reimbursement, but de-
creased profitability, under Medicare payment. When com-
plications occurred, cost increased from $23,101 to
$48,180, reimbursement increased from $23,231 to $35,651
and profitability fell from a gain of $131 to a loss of
$12,528.
There were no statistically significant differences in
demographics or health-related attributes between study
groups. This suggests that patient baseline health status
cannot explain the cause or risk of complications ob-
served. However, there were minor, non–statistically sig-
nificant differences between our study groups. Patients
who experienced major complications tended to be
older, were assigned a higher preoperative ASA classifi-
cation and were more likely to be male. Each of these
factors could independently impact cost and profitability.
We used a powerful matching algorithm to generate
nearly perfectly matched study groups to control for
these effects. Interestingly, the financial impact of major
complications was even greater between the matched
study groups than the original unmatched groups. This
provides strong support for the assertion that the ob-
served differences in financial outcomes were driven by
the occurrence of complications rather than by variabil-
ity between groups.
We used multivariate linear regression to evaluate the
impact of complication status, age/age-squared, ASA
classification, BMI and gender on cost, reimbursement,
profitability and LOS. Only complication status had a
statistically significant impact on outcomes, increasing
total cost by $24,889, increasing reimbursement by
$12,326 and decreasing profitability by $12,563. Theresults of multivariate analyses performed on the
matched sample were nearly identical. This further sup-
ports the argument that complication status, rather than
other factors, independently drives financial perform-
ance and strongly suggests that hospitals could benefit
financially by preventing complications.
LOS has an important but underappreciated impact
on hospital finances. Any event that prolongs LOS gen-
erates an opportunity cost for hospitals, especially as the
health care environment is moving toward bundled pay-
ment [17,18]. Whenever a patient’s LOS is prolonged,
the hospital’s available bed capacity is decreased, thus
limiting the hospital’s ability to admit additional
revenue-generating patients. The cost of a missed admis-
sion is equal to the expected revenue minus the ex-
pected variable cost (that is, the contribution margin).
Because variable costs make up a small component of a
hospital’s total costs, the contribution margin will nearly
always be large and positive. We found that complica-
tions more than doubled the LOS, indicating that the
hospital could treat two uncomplicated patients in the
same time required to treat single patients who experi-
enced a major complication. Thus, our data indicate that
hospitals suffer financially in at least two ways when
complications occur: first, through lower expected profit
margins due to treating patients who experience compli-
cations, and second, via the opportunity cost generated
when capacity is consumed by prolonged hospital LOS.
Medicare has recently started to deny payment for se-
lected diagnoses when readmissions occur within 30 days
of discharge, including congestive heart failure, myocar-
dial infarction and pneumonia [19]. This policy will
eventually be extended to include other conditions, in-
cluding readmissions related to surgical complications.
For the purposes of this study, we assumed that all
Table 3 Relationships between major surgical complications and cost, reimbursement, total margin and length of stay, controlling for effects of age, gender,
American Society of Anesthesiology score and body mass indexa























Complication $24,889b $15,610b $9,228b $12,326b −$12,563b 8.29b $26,269b $16,368b $9,846b $12,138b −$14,131b 8.456b
(2,024) (1,246) (799) (1,272) (2,083) (0.607) (4,168) (2,566) (1,634) (2,175) (4,022) (1.116)
Age -$118 −$54 −$63 −$153 −$35 −0.135 $854 $572 $281 $16 −$838 0.256
(393) (242) (155) (247) (404) (0.118) (1,498) (922) (587) (782) (1,445) (401)
Age-squared $1 $1 $1 $1 $0 0.001 −$8 −$6 −$3 $0 $8 −0.002
(3) (2) (1) (2) (3) (0.001) (12) (7) (5) (6) (12) (0.003)
Female gender $2,047 $1,258 $796 −$578 −$2,625 0.493 $4,442 $2,698 $1,759 −$991 −$5,432 1.093
(1,680) (1,034) (663) (1,056) (1,729) (0.504) (4,313) (2,655) (1,691) (2,251) (4,161) (1.154)
ASA score $2,598 $1,397 $1,200 $1,391 −$1,207 0.611 $2,272 $1,194 $1,074 −$159 −$2,430 0.411
(1,758) (1,082) (694) (1,104) (1,809) (0.528) (4,755) (2,927) (1,864) (2,482) (4,588) (1.272)
BMI $53 $38 $16 −$110 −$163 0.006 −$51 −$17 −$34 −$208 −$158 −0.024
(121) (75) (48) (76) (125) (0.036) (375) (231) (147) (196) (362) (0.100)
Constant $15,636 $9,791 $5,797 $27,531b $11,895 8.011c −$2,900 −$2,330 −$584 $31,214 $34,114 0.494
(11,860) (7,298) (4,682) (7,450) (12,202) (3.559) (45,162) (27,804) (17,704) (23,573) (43,578) (12,090)c
Observations 276 276 276 276 276 276 100 100 100 100 100 100
R2 0.3764 0.3835 0.3509 0.2733 0.1391 0.4290 0.3137 0.3197 0.2945 0.2600 0.1496 0.3928
aASA: American Society of Anesthesiology; BMI: Body mass index; LOS: Length of stay. bP < 0.001. cP < 0.05. All values were obtained using multiple linear regression techniques as described in the Methods section.

















Flynn et al. Perioperative Medicine 2014, 3:1 Page 7 of 9
http://www.perioperativemedicinejournal.com/content/3/1/1readmissions were reimbursed fully by Medicare. Denial
of payment for readmissions would result in losses
greater than those calculated in this study, thus provid-
ing additional incentives for hospitals to prevent compli-
cations and the readmissions that frequently accompany
them.
Eappen and coauthors [17] found that surgical compli-
cations were associated with increased total margin for
commercially insured patients but decreased total mar-
gin for patients who were self-insured or covered by
Medicare or Medicaid. Owing to the relatively small
sample size in our study, we assumed that all patients
were insured by Medicare, thus eliminating the impact
of payer mix on our results. In contrast to the findings
of Eappen et al., however, when we used actual payment
received in the analysis, regardless of payer type, patients
who experienced complications generated negative mar-
gins (losses averaging nearly $8,000/patient), whereas
uncomplicated patients generated positive margins
(gains of nearly $1,200/patient). This suggests that the fi-
nancial incentive to prevent complications is preserved
when actual payment is considered at our institution.
In this study, we did not evaluate the impact of indi-
vidual types of complications on financial performance
or the preventability of different complications. Previous
studies have demonstrated that certain complications
are far more expensive to treat than others [20,21]. Add-
itionally, certain complications may be far more difficult
to prevent than others, whereas some complications
may simply be inevitable because of the underlying dis-
ease burden of surgical patients. From a strictly financial
standpoint, treatment of patients with complications that
are both preventable and associated with the highest
cost should be prioritized.
This study has several limitations that warrant discus-
sion. First, physicians’ professional fees and payments
were not included in the analyses, so our results may
understate both the increase in cost and reimbursement
associated with complications. Second, because our
chart review was limited to a single hospital, patients
whose readmissions occurred at other hospitals were not
included in our analysis. Although it may have been
feasible for us to contact all study patients and inquire
about readmissions elsewhere, we used retrospective
data in this study. The only potentially link of patients
to this study would have been direct contact for a re-
search telephone call, which they did not consent to at
the time of procedure. Third, although we modeled re-
imbursement by assuming all patients were insured
through Medicare, our study population might not be
representative of the Medicare population. The average
age of patients in each complication group, for example,
was slightly less than the minimum age of 65 years at
which patients become eligible for Medicare benefits.The fourth limitation concerns the generalizability of
this study to other settings. All of the data in this study
derived from a single US institution, with its own unique
cost structure and patient population. Thus, it is difficult
to predict how accurately the cost increases found in
this study would predict changes in cost associated with
complications at other hospitals. Moreover, hospitals op-
erating outside of the United States generate revenue
based on the financing systems of their home countries,
which may differ significantly from the MS-DRG rates
used in this study to determine reimbursement and cal-
culate margins. In many countries, however (for ex-
ample, England, France and Germany) the methods used
to derive rates (or tariffs) share many similarities to
Medicare’s MS-DRGs, including adjustment for patients’
comorbidities, complications and local market forces
[22]. Therefore, we can predict that both costs and pay-
ments in these settings would increase when complica-
tions occur, but additional research is required to
determine the extent to which payment increases offset
increased expenditures.
Conclusions
Our results provide a strong argument for financial in-
vestment in quality improvement from the perspective
of the hospital administrator. Increases in Medicare re-
imbursement resulting from postoperative complications
are not large enough to compensate the hospital for the
increase in total costs associated with complications.
Prevention of surgical complications therefore can
help to improve care quality while improving cost-
effectiveness.
Appendix: the US Medicare system
Medicare is a social health insurance program admin-
istered by the US Department of Health and Human
Services. Eligible beneficiaries include Americans ages
65 or older as well as Americans of any age with cer-
tain chronic diseases. Medicare is a large source of
payment for inpatient hospital care in the United
States, comprising 27% of all acute care hospital rev-
enue in 2012 [23].
Medicare payment is broken into different compo-
nents, each of which pays for different aspects of
medical care. Medicare Part A (hospital insurance)
pays for inpatient hospital care, home health care,
skilled nursing facilities and hospice care. Medicare
Part B (supplementary medical insurance) pays for
outpatient physician and nursing services, diagnostic
imaging and testing, and outpatient hospital proce-
dures. Medicare Part D (prescription drug plan) is a
voluntary, premium-based program that helps to
subsidize the cost of prescription drugs for Medicare
beneficiaries.
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nanced by the Medicare inpatient prospective pay-
ment system. Each hospital is paid a predetermined
amount per discharge based on the beneficiary’s clin-
ical condition and treatment strategy, which are cap-
tured through MS-DRGs. The payment rates for each
MS-DRG are updated each year in an attempt to ac-
count for the average cost of resources required to
treatment patients in that MS-DRG. Payments for in-
dividual hospitals are further adjusted on the basis of
geographic differences with regard to labor prices,
costs of providing graduate medical education and
compensation of hospitals that provide care to a dis-
proportionate share of low-income patients.
The MS-DRG system consists of 335 base DRGs,
which are split into two or three MS-DRGs on the
basis of the presence of one or more complications
or comorbidities (CCs) or major CCs. For example, a
healthy patient who undergoes a colectomy with no
resulting complications may be assigned MS-DRG 331
(major small- or large-bowel procedures without
CCs), whereas a patient with multiple comorbidities
may be assigned MS-DRG 330 (major small- or large-bowel
procedures with CCs) and a patient who experiences a
serious complication may be assigned MS-DRG 329
(major small- or large-bowel procedure with major CCs).
Accordingly, the hospital would receive the highest
payment for MS-DRG 329, less for MS-DRG 330 and
the least for MS-DRG 331.
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